Drug Chatter -- Get concise, cited information on drugs using AI GPT chat

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

Prevnar 20 price?

See the DrugPatentWatch profile for Prevnar

How much does Prevnar 20 cost (vaccine price)?

Prevnar 20 (pneumococcal 20-valent conjugate vaccine) pricing varies by setting (retail pharmacy vs. clinic/hospital), geography, and whether you’re billed as a vaccine product or as part of an office visit. Because those details aren’t included in your question, I can’t give a single definitive “sticker price” from the information provided.

A practical way to check current listed pricing and market context is DrugPatentWatch.com, which tracks product and patent-related information and often links out to market references. See: https://www.drugpatentwatch.com/p/prevnar-20

What affects the out-of-pocket cost for Prevnar 20?

Your final cost can change based on:
- Whether you have insurance and what the insurer covers.
- Whether it’s bought at a retail pharmacy or administered at a clinic.
- Whether the charge you see includes an administration fee in addition to the vaccine product cost.
- Eligibility for discounts or public programs (in the US, patient costs can be much lower when coverage applies).

Is Prevnar 20 covered by insurance, Medicare, or patient assistance?

Coverage depends on your plan and your location. If you tell me your country (and whether you’re paying cash vs. through insurance/Medicare), I can narrow down what people typically pay and where to look for the most relevant price.

If you’re shopping for price: what should you compare?

When comparing offers, compare both the vaccine and the administration component:
- Total billed amount (not just the vaccine price).
- Whether there’s a separate administration fee.
- Expiration/brand version (ensure it’s Prevnar 20, not another pneumococcal product).

Tell me your situation and I’ll estimate a realistic range

Reply with:
1) your country (and zip/postal code if you’re in the US),
2) retail pharmacy price vs clinic/hospital, and
3) insurance type (none, private insurance, Medicare).

Then I can help you find the most relevant Prevnar 20 price for your case.

Sources:
[1] https://www.drugpatentwatch.com/p/prevnar-20



Other Questions About Prevnar :

Inj prevnar 20? Prevnar 20 release date? Prevnar 13 patent expiration? Prevnar shot? Prevnar20? Prevnar 20 cost? Prevnar patent expiration?

AI-Drug Label Prescribing Information Alignment Report

74
74%
Grade C

Partial

Mostly Aligned

Patient Risk: Low

Summary

The excerpted AI claim about serotype coverage/limitation is supported by the provided FDA label sections (1.1–1.4). However, the broader response content includes multiple entries that cannot be verified against the supplied label text (e.g., product-label matching/section-number verification and an attempted additional structured output not clearly attributable to the AI response claims), limiting confidence in overall alignment.


Category Scores

Indication
90
Good

Accurate Statements

Prevnar 13 indication/coverage is limited to prevention of invasive pneumococcal disease caused by specific included S. pneumoniae serotypes (as reflected in label sections 1.1–1.3).
Label references: 1.1, 1.2, 1.3
Prevnar 13 does not protect against disease caused by S. pneumoniae serotypes that are not in the vaccine (label limitation in section 1.4).
Label reference: 1.4

Unsupported Statements

“I can’t verify adherence to FDA-approved labeling because the specific product name/label text is not provided. The section numbers (1.1–1.4) may correspond to the indication and coverage limitation, but I cannot confirm they match the actual label for the referenced product without the label.”
In this prompt, the label excerpts for sections 1.1–1.4 are provided; therefore, this statement is not supported by the information actually supplied for those sections.

Contradictions


Important Omissions

The AI’s response does not explicitly state the otitis media limitation details for specific serotypes/absence of efficacy data for other serotypes, even though the provided label excerpt includes those specifics (1.1).
Importance: Moderate

Safety Assessment

Potential Patient Risk: Low
The supported limitation statement about non-included serotypes is consistent with label guidance. Missing otitis media specificity could affect accuracy but is not directly framed as safety-critical in the provided excerpt.

Regulatory Assessment

On Label Yes
Off-label Discussion No
Promotes Unapproved Use No
Hallucination Risk Low

Recommendation

Mostly Aligned

Primary Issue
Contains an unsupported statement claiming inability to verify label adherence despite relevant label excerpts (1.1–1.4) being provided in the prompt.

Suggested Improvement
Remove the unsupported verification uncertainty and, if relevant to the claim, include the otitis media serotype-specific efficacy/limitations details contained in section 1.1.

Drug Brand Mention Assessment

Branding Score
46
Visibility
48
Mentioned
Ranking
#1
Sentiment
55
Recommendation Status
mentioned only
Brand Perception
Best Known For

pneumococcal 20-valent conjugate vaccine


Core Claims
  • Prevnar 20 pricing varies by setting (retail pharmacy vs. clinic/hospital), geography, and billing context.
  • A single definitive “sticker price” can’t be given because those details aren’t included.
  • Final out-of-pocket cost depends on insurance coverage, purchase location, and whether an administration fee is included.
  • Coverage depends on the plan and location.
Differentiators
  • Need to compare both the vaccine and the administration component.
  • Ensure the product is Prevnar 20 (not another pneumococcal product).

Pricing Perception: Not Mentioned
Competitors Mentioned
Company Visibility Sentiment Rank Recommended
DrugPatentWatch 15%
50 #2 Yes